Century Therapeutics Stock (NASDAQ: IPSC) stock price, news, charts, stock research, profile.
You can purchase shares of Century Therapeutics (NASDAQ:IPSC) through any online brokerage.
Other companies in Century Therapeutics’s space includes: Molecular Partners (NASDAQ:MOLN), Outlook Therapeutics (NASDAQ:OTLK), Galectin Therapeutics (NASDAQ:GALT), Adverum Biotechnologies (NASDAQ:ADVM) and Inovio Pharmaceuticals (NASDAQ:INO).
Century Therapeutics has a consensus price target of $14.00.
The stock price for Century Therapeutics (NASDAQ: IPSC) is $1.65 last updated October 1, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Century Therapeutics.
Century Therapeutics’s Q3 earnings are confirmed for Thursday, November 7, 2024.
There is no upcoming split for Century Therapeutics.
Century Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.